Zydus Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 172.50 Cr
- Paid Up Capital ₹ 100.62 Cr
- Company Age 29 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1,500.00 Cr
- Satisfied Charges ₹ 3,001.83 Cr
- Revenue Growth 13.72%
- Profit Growth 78.25%
- Ebitda 27.96%
- Net Worth 3.01%
- Total Assets 15.92%
About Zydus Lifesciences
Zydus Lifesciences Limited (ZLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 15 May 1995 and has a history of 29 years and eight months. Its registered office is in Ahmedabad, Gujarat, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532321 and on the National Stock Exchange(NSE) under CADILAHC.
The Corporate was formerly known as Cadila Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 172.50 Cr and a paid-up capital of Rs 100.62 Cr.
The company currently has active open charges totaling ₹1,500.00 Cr. The company has closed loans amounting to ₹3,001.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Zydus Lifesciences Limited India are Nitinkumar Parekh as CFO and Dhavlal Soni as Company Secretary. Ganesh Nayak, Apurva Diwanji, Mukesh Patel, and Six other members serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
Industry
What products or services does Zydus Lifesciences Limited offer?
Zydus Lifesciences Limited offers a wide range of products and services, including Pharmaceutical Services, Biotechnology Services.
Who are the key members and board of directors at Zydus Lifesciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharvil Patel  | Managing Director | 01-Aug-1997 | Current |
| Nitinkumar Parekh | CFO | 10-Feb-2015 | Current |
| Dhavlal Soni | Company Secretary | 07-Feb-2019 | Current |
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mukesh Patel | Director | 01-Aug-1997 | Current |
| Ganesh Nayak | Whole-Time Director | 12-Jul-2017 | Current |
| Apurva Diwanji | Director | 13-May-2016 | Current |
| Bhadresh Shah | Director | 06-Dec-2018 | Current |
| Pankaj Patel | Director | 15-May-1995 | Current |
| Shelina Parikh | Director | 17-May-2024 | Current |
Financial Performance of Zydus Lifesciences.
Zydus Lifesciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.72% increase. The company also saw a substantial improvement in profitability, with a 78.25% increase in profit. The company's net worth moved up by a moderate rise of 3.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zydus Lifesciences?
In 2024, Zydus Lifesciences had a promoter holding of 74.98% and a public holding of 25.01%. The company had 16 Subsidiaries and 3 Joint Ventures. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zydus Wellness Products LimitedSharvil Patel is a mutual person
Zydus Wellness LimitedGanesh Nayak, Sharvil Patel and 1 more are mutual person
Zydus Hospira Oncology Private LimitedGanesh Nayak is a mutual person
Zydus FoundationPankaj Patel and Sharvil Patel are mutual person
Tuv India P LtdApurva Diwanji is a mutual person
Zydus Takeda Healthcare Private LimitedGanesh Nayak and Pankaj Patel are mutual person
Charges (Loans)
₹1,500.00 Cr
₹3,001.83 Cr
Charges Breakdown by Lending Institutions
- Others : 1500.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Dec 2012 | Others | ₹1,500.00 Cr | Open |
| 24 Dec 2015 | Citi Bank N.A. | ₹225.00 Cr | Satisfied |
| 07 Aug 2014 | Citi Bank N.A. | ₹93.00 Cr | Satisfied |
| 28 May 2014 | Others | ₹120.40 Cr | Satisfied |
| 21 Nov 2013 | Citi Bank N.A. | ₹94.50 Cr | Satisfied |
How Many Employees Work at Zydus Lifesciences?
Zydus Lifesciences has a workforce of 13762 employees as of Jan 16, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zydus Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zydus Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
